Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Resources plc Regulatory News (PANR)

Share Price Information for Pantheon Resources plc (PANR)

Share Price is delayed by 15 minutes
Get Live Data
13.52    -0.37 (-2.66%)
Bid:
13.51
Ask:
14.00
Spread: 0.49 (3.627%)
Market Cap: £197.11m
PANR Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Resources plc Share Chart

AIM Rule 17 and Schedule 2(g) Update

16 Apr 2021 13:12

RNS Number : 7738V
Pantheon Resources PLC
16 April 2021
 

16 April, 2021

Pantheon Resources plc

AIM Rule 17 and Schedule 2(g) Update

 

Pantheon Resources plc ("Pantheon" or "the Company"), announces the following updates to disclosure in relation to Jay Cheatham, CEO of the Company, pursuant to AIM Rule 17 and Schedule 2(g)(iii) to (viii) of the AIM Rules.

 

As previously announced, Pantheon has completely exited its East Texas assets. As part of this exit, and as disclosed in its annual account to 30 June 2020 announced on 27 January 2021, Vision Resources LLC filed for Chapter 7 Bankruptcy in the United States Bankruptcy Court for the Southern District of Texas Houston Division on 28 April 2020. These bankruptcy proceedings remain ongoing but are expected to be concluded later this year.

 

In connection with these bankruptcy proceedings the Company provides the following updates in relation to Jay Cheatham, Chief Executive of the Company, pursuant to AIM Rule 17 and Schedule 2(g)(iii) to (viii) of the AIM Rules.

 

Mr Cheatham was Sole Manager and CEO of Vision Resources LLC and Vision Gas Limited, and President and CEO of Vision Operating Company LLC, all of which are part of the above bankruptcy proceedings which commenced on 28 April 2020 and remain ongoing.

 

 

 

 

-Ends-

Further information:

 

Pantheon Resources plc

+44 20 7484 5361

Jay Cheatham, CEO

Justin Hondris, Director, Finance and Corporate Development

 

Canaccord Genuity plc (Nominated Adviser and broker)

Henry Fitzgerald-O'Connor, James Asensio, Angelos Vlatakis

 

+44 20 7523 8000

Blytheweigh

Tim Blythe, Megan Ray, Alice Mclaren, Madeleine Gordon-Foxwell

+44 20 7138 3204

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIFSAIRLIL
Date   Source Headline
2nd Jun 20267:00 amRNSAlaska Legislature Appearance & Op. Update
1st May 20262:37 pmRNSBlocklisting Interim Update
27th Apr 20265:05 pmRNSVesting of Previously Granted RSUs and TVR
23rd Apr 202611:12 amRNSOperational Update and Change of Accounting Date
13th Apr 20265:20 pmRNSGranting RSU's and Blocklisting Application
31st Mar 20267:00 amRNSUnaudited Interim Results
12th Mar 20267:00 amRNSBoard Changes, AGM & Webinar Update
12th Mar 20267:00 amRNSBoard Changes, AGM & Webinar Update
6th Mar 20267:00 amRNSChange of Directorship
16th Feb 20267:00 amRNSAGM Arrangements & Corporate Update
4th Feb 20268:05 amRNSNotice of AGM
4th Feb 20267:00 amRNSNotice of AGM
15th Jan 202610:10 amRNSPlacing to raise $10 Million
30th Dec 20257:11 amRNSFinal Results for the Year Ended 30 June 2025
30th Dec 20257:11 amRNSFinal Results for the Year Ended 30 June 2025
24th Dec 202512:06 pmRNSTR-1: Notification of major holdings
24th Dec 202512:06 pmRNSTR-1: Notification of major holdings
22nd Dec 20257:00 amRNSShareholder Letter and Corporate Update on Dubhe-1
22nd Dec 20257:00 amRNSShareholder Letter and Corporate Update on Dubhe-1
17th Dec 202510:00 amRNS-RUpdate - Investor Webinar rescheduling
15th Dec 20251:55 pmRNSFinal Repayment of Convertible Bonds & Webinar
15th Dec 20257:00 amRNSRetirement of Director
2nd Dec 20257:00 amRNSOperational Update - Dubhe-1
12th Nov 20257:00 amRNSParticipation in Conference and Update on Dubhe-1
8th Oct 20257:00 amRNSDubhe-1 Operational Update
18th Sep 20257:00 amRNSDubhe-1 Operational Update - Ready for Completion
11th Sep 20252:20 pmRNSPlacing and Subscription to raise $30 Million
8th Sep 20257:00 amRNSDubhe-1 Update
3rd Sep 20259:54 amRNS-RInvestor Presentation via Investor Meet Company
18th Aug 20257:00 amRNSDubhe-1 Appraisal Well Exceeds Pre-Drill Estimates
24th Jul 20253:45 pmRNSVesting of RSUs, Grant of Awards & Blocklisting
22nd Jul 20259:45 amRNSSpudding of Dubhe-1 well
15th Jul 20257:00 amRNSTR-1: Notification of major holdings
10th Jul 20257:00 amRNSOperating Update, Webinar, and Total Voting Rights
8th Jul 202511:45 amRNS-RRescheduling of Investor Meet Company Webinar
7th Jul 20257:00 amRNSPlacing and Subscription to Raise $16.25 Million
1st Jul 20257:00 amRNSChange of Registered Office
10th Jun 20257:00 amRNSMarty Rutherford Appointed to Board of Directors
9th Jun 20257:05 amRNSNew Executive Team Appointments
21st May 20257:00 amRNSFurther Results from the Flow Testing of Megrez-1
19th May 20257:00 amRNSFurther Results from the Flow Testing of Megrez-1
22nd Apr 20257:00 amRNS-RInvestor Meet Company Webinar
14th Apr 20257:11 amRNSPreliminary Results from Flow Testing at Megrez 1
3rd Apr 20257:00 amRNS-RParticipation in Upcoming Investor Conferences
27th Mar 202510:00 amRNSDirector Dealing
25th Mar 20257:00 amRNSEmployee Share Ownership Plan Awards for 2025
25th Mar 20257:00 amRNSClosing of US$35 million Convertible Bond Issuance
24th Mar 20257:11 amRNSUnaudited Interim Results
17th Mar 20257:00 amRNSQuarterly Repayment of Unsecured Convertible Bonds
12th Mar 20254:50 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.